LETAIRIS for LETAIRIS ...
2 FULL PRESCRIBING INFORMATION WARNING: EMBRYO-FETAL TOXICITY Do not administer Letairis to a pregnant female because it may cause fetal harm.
Tags:
Letairis for letairis, Letairis
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
-800 GILEAD5 or FDA at 1800 FDA 1088 or …
www.gilead.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYDELIG safely and effectively. See full prescribing information
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.gilead.com3 full prescribing information warning: posttreatment acute exacerbation of hepatitis b and risk of drug resistance with use of truvada for hiv-1 pre-
AmBisome (amphotericin B) liposome for injection
www.gilead.com5 Pediatric and Elderly Patients The pharmacokinetics of amphotericin B after administration of AmBisome in pediatric and elderly patients has not been studied; however, AmBisome has
(incidence greater than or equal to 10%, Grades 2
www.gilead.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIREAD safely and effectively. DSee full prescribing information …
Information, Highlights, Prescribing, Prescribing information, Highlights of prescribing information, Viread
for BIKTARVY. BIKTARVY ...
www.gilead.comGilead Sciences 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BIKTARVY safely and effectively.
AMENDED AND RESTATED LICENSE AGREEMENT …
www.gilead.comFinal Version 1 AMENDED AND RESTATED LICENSE AGREEMENT (TEMPLATE) This AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”) is made as of July __, 2011 (the “Effective Date”) by and between Gilead Sciences, Inc. a
Agreement, Sciences, License, Template, Amended, Restated, Gilead, Gilead sciences, Amended and restated license agreement
HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, …
www.gilead.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, or 6 These highlights do not include all the information needed to use HARVONI ® safely and effectively. See full prescribing information
MEDICATION GUIDE ZYDELIG (zye-DEL-ig) …
www.gilead.comMEDICATION GUIDE ZYDELIG® (zye-DEL-ig) (idelalisib) tablets What is the most important information I should know about Zydelig? Zydelig can cause serious side effects that can lead to death, including:
Guide, Medication, Medication guide zydelig, Zydelig, Zye del
HIGHLIGHTS OF PRESCRIBING INFORMATION should only be …
www.gilead.com1 INDICATIONS AND USAGE . 1.1 HIV-1 Infection . VIREAD ® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric …
Hepatitis B and C Treatment Expansion - gilead.com
www.gilead.comProviding treatment for chronic viral hepatitis B (HBV) and hepatitis C (HCV) infection is a key focus of Gilead Sciences. We make it a priority to expand access to treatment for appropriate patients in need in developing countries.
Related documents
Product Information Zyrtec - Medicines
www.medicines.org.auZyrtec PI Page 1 of 8 Australia J&J Pacific 3rd April 2014 1 of 8 Product Information Zyrtec NAME OF THE MEDICINE Cetirizine hydrochloride DESCRIPTION Cetirizine hydrochloride is an orally active, H
Information, Product, Descriptions, Medicine, Product information zyrtec, Zyrtec
for Herbal Medicines
www.travolekar.ruIV PDR FOR HERBAL MEDICINES Foreword With 150,000 copies of its first edition in print, PDR for Herbal Medicines has almost instantly become one
THE FALSIFIED MEDICINES DIRECTIVE (FMD) …
www.perfectdossier.comPerfect Pharmaceutical Consultants Pvt Limited ©Copyright Perfect Pharmaceutical Consultants Pvt. Limited, Oct. 2012.All rights reserved. THE FALSIFIED MEDICINES DIRECTIVE (FMD)
Directive, Medicine, The falsified medicines directive, Falsified
COMMITTEE FOR PROPRIETARY MEDICINAL …
www.ema.europa.euCPMP_QWP_486_95 1/6 MANUFACTURE OF THE FINISHED DOSAGE FORM Note for Guidance Concerning the application of Part 2, section B of …
Finished, Manufacture, Dosage, Manufacture of the finished dosage
General guidance on hold‑time studies
www.who.intAnnex 4 93 Stage Test to be carried out as per specification Study time Coated tablets (in bulk container) Description, appearance or visual examination, hardness,
General, Time, Guidance, Studies, Descriptions, Hold, General guidance on hold time studies
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines Pharmaceutical & Analytical 2.02 PA Jun11 v6 showing changes.doc Page June 2011 1 of 27 MEDICINES CONTROL COUNCIL PHARMACEUTICAL AND ANALYTICAL
for BIKTARVY. BIKTARVY ...
www.gilead.comGilead Sciences 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BIKTARVY safely and effectively.